Magnetic N-succinyl chitosanalginate beads for carbamazepine delivery

Drug Development and Industrial Pharmacy

Volumn 36, Issue 11, 2010, Pages 1286-1294

  Liu, Hui Juan ^a   Li, Ping ^a   Wei, Qin ^a  

^a LANZHOU UNIVERSITY   (China)

Author keywords

Carbamazepine; Delivery properties; Hydrogel; N succinyl chitosan; Superparamagnetic

Indexed keywords

ALGINIC ACID; CALCIUM CHLORIDE; CARBAMAZEPINE; CHITOSAN; HYDROCHLORIC ACID; MAGNETITE; N SUCCINYL CHITOSAN; PHOSPHATE BUFFERED SALINE; UNCLASSIFIED DRUG;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; HYDROGEL; INFRARED SPECTROSCOPY; MAGNETISM; NANOENCAPSULATION; SUSTAINED DRUG RELEASE;

ALGINATES; ANTICONVULSANTS; CARBAMAZEPINE; CHITOSAN; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; EPILEPSY; FERRIC COMPOUNDS; GLUCURONIC ACID; HEXURONIC ACIDS; MAGNETICS;

EID: 77956921292     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639041003758689     Document Type: Article

References (29)

1. Chang BS, Lowenstein DH. (2003). Epilepsy. N Engl J Med, 349:1257-1266
2. Kwan P, Brodie MJ. (2000). Early identification of refractory epilepsy. N Engl J Med, 342:314-319
3. Ramon C, Holmes MD, Haueisen J, Schimpf PH, Freeman WJ. (2007). Scalp potentials and magnetic fields of a fully and partially activated central sulcus. Int Congr Ser, 1300:157-160
4. Jung H, Milán RC, Girard ME, León F, Montoya MA. (1997). Bioequivalence study of carbamazepine tablets: In vitro/in vivo correlation. Int J Pharm, 152:37-44.
5. El-Massik MA, Abdallah OY, Galal S, Daabis NA. (2006). Towards a universal dissolution medium for carbamazepine. Drug Dev Ind Pharm, 32:893-905.
6. Sethia S, Squillante E. (2002). Physicochemical characterization of solid dispersions of carbamazepine formulated by supercritical carbon dioxide and conventional solvent evaporation method. J Pharm Sci, 91:1948-1957
7. Sethia S, Squillante E. (2004). Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods. Int J Pharm, 272:1-10.
8. Rustichelli C, Gamberini G, Ferioli V, Gamberini MC, Ficarra R, Tommasini S. (2000). Solid-state study of polymorphic drugs: Carbamazepine. J Pharm Biomed Anal, 23:41-54.
9. Dong WY, Maincent P, Bodmeier R. (2007). In vitro and in vivo evaluation of carbamazepine-loaded enteric microparticles. Int J Pharm, 331:84-92.
10. Boison D. (2009). Engineered adenosine-releasing cells for epilepsy therapy: Human mesenchymal stem cells and human embryonic stem cells. Neurotherapeutics, 6:278-283
11. Vajda FJE. (2007). Pharmacotherapy of epilepsy: New armamentarium, new issues. J Clin Neurosci, 14:813-823
12. Nilsen KE, Cock HR. (2004). Focal treatment for refractory epilepsy: Hope for the future? Brain Res Brain Res Rev, 44:141-153
13. KatoY, Onishi H, Machida Y. (2004). N-succinyl-chitosan as a drug carrier: Water-insoluble and water-soluble conjugates. Biomaterials, 25:907-915
14. Yan CY, Chen DW, Gu JW, Hu HY, Zhao XL, Qiao MX. (2006). Preparation of N-succinyl-chitosan and their physical-chemical properties as a novel excipient. Pharm Soc Japan, 126:789-793
15. Chen LY, Tian ZG, Du YM. (2004). Synthesis and pH sensitivity of carboxymethyl chitosan-based polyampholyte hydrogels for protein carrier matrices. Biomaterials, 25:3725-3732
16. Liu ZH, Jiao YP, Zhang ZY. (2007). Calcium-carboxymethyl chitosan hydrogel beads for protein drug delivery system. J Appl Polym Sci, 103:3164-3168
17. Yan LF, Qian F, Zhu QS. (2001). Interpolymer complex polyampholytic hydrogel of chitosan and carboxymethyl cellulose (CMC): Synthesis and ion effect. Polym Int, 50:1370-1374
18. Yang WC, Xie R, Pang XQ, Ju XJ, Chu LY. (2008). Preparation and characterization of dual stimuli-responsive microcapsules with a superparamagnetic porous membrane and thermoresponsive gates. J Memb Sci, 321:324-330
19. Liu XQ, Kaminski MD, Chen HT, Torno M, Taylor LT, Rosengart AJ. (2007). Synthesis and characterization of highly-magnetic biodegradable poly (D,L-lactide-co-glycolide) nanospheres. J Control Release, 119:52-58
20. Dai YN, Li P, Zhang JP, Wang AQ, Wei Q. (2008). A novel pH sensitive N-succinyl chitosan/alginate hydrogel bead for nifedipine delivery. Biopharm Drug Dispos, 29:173-184
21. Dai YN, Li P, Zhang JP, Wang AQ, Wei Q. (2008). Swelling characteristics and drug delivery properties of nifedipine-loaded pH sensitive alginate-chitosan hydrogel beads. J Biomed Mater Res, 86B:493-500.
22. Elizabeth J, Donner O. (2006). Carter Snead III. New generation anticonvulsants for the treatment of epilepsy in children. NeuroRX, 3:170-180
23. Mladenovska K, Cruaud O, Richommed P, Belamie E, Raicki RS, Venier-Julienne MC, et al. (2007). 5-ASA loaded chitosan-Ca-alginate microparticles: Preparation and physicochemical characterization. Int J Pharm, 345:59-69.
24. Shu XZ, Zhu KJ. (2002). The release behavior of brilliant blue from calcium-alginate gel beads coated by chitosan: The preparation method effect. Eur J Pharm Biopharm, 53:193-201.
25. Sankalia MG, Mashru RC, Mashru JM, Sutariya VB. (2007). Reversed chitosan-alginate polyelectrolyte complex for stability improvement of alpha-amylase: Optimization and physicochemical characterization. Eur J Pharm Biopharm, 65:215-232
26. Chen SC, Wu YC, Mi FL, Lin YH, Yu LC, Sung HW. (2004). A novel pH-sensitive hydrogel composed of N, O-carboxymethyl chitosan and alginate cross-linked by genipin for protein drug delivery. J Control Release, 96:285-300.
27. Hoffman AS. (2002). Hydrogels for biomedical applications. Adv Drug Deliv, 43:3-12.
28. Xu YM, Zhan CY, Fan LH, Wang L, Zheng H. (2007). Preparation of dual crosslinked alginate-chitosan blend gel beads and in vitro controlled release in oral site-specific drug delivery system. Int J Pharm, 336:329-337
29. Xi FN, Wu JM, Jia ZS, Lin XF. (2005). Preparation and characterization of trypsin immobilization on silica gel supported macroporous chitosan bead. Process Biochem, 40:2833-2840